• LAST PRICE
    1.0500
  • TODAY'S CHANGE (%)
    Trending Down-0.0200 (-1.8692%)
  • Bid / Lots
    1.0400/ 7
  • Ask / Lots
    1.1000/ 2
  • Open / Previous Close
    1.0600 / 1.0700
  • Day Range
    Low 1.0400
    High 1.1000
  • 52 Week Range
    Low 0.8075
    High 2.1200
  • Volume
    59,532
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.07
TimeVolumeOKYO
09:32 ET3331.06
09:33 ET8911.0601
09:48 ET1501.075
09:50 ET1501.0871
09:51 ET1501.075
09:53 ET2001.07
10:02 ET19431.06
10:08 ET1001.0543
10:22 ET2001.06
10:31 ET2001.07
10:47 ET5001.0694
10:49 ET1001.065
10:54 ET24001.0671
10:58 ET1001.07
11:00 ET10001.07
11:02 ET1151.0694
11:03 ET134401.0699
11:09 ET12871.0707
11:12 ET5001.1
11:14 ET77801.07
11:16 ET3001.0831
11:21 ET11101.099
11:38 ET25001.06
11:41 ET1001.06
11:48 ET7001.05
11:54 ET11661.0406
11:59 ET2001.0497
12:06 ET7471.0407
12:21 ET13001.05
12:50 ET16001.045
12:53 ET3001.05
01:26 ET2001.05
01:44 ET4001.05
01:51 ET6001.05
02:14 ET3001.045
02:16 ET1001.05
02:18 ET3001.05
02:21 ET1001.0495
02:32 ET15001.05
02:34 ET2001.045
02:38 ET17001.0405
02:41 ET1001.04
02:52 ET1001.05
02:54 ET41241.04
02:56 ET1001.047
02:57 ET5001.0476
03:14 ET8451.0463
03:30 ET6001.0451
03:39 ET8001.045
03:42 ET6001.0476
03:44 ET6001.0498
03:46 ET1411.05
03:48 ET5001.0496
03:51 ET1001.05
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesOKYO
OKYO Pharma Ltd
35.5M
-1.5x
---
United StatesGANX
Gain Therapeutics Inc
44.7M
-1.5x
---
United StatesSER
Serina Therapeutics Inc
44.9M
-1.1x
---
United StatesATNM
Actinium Pharmaceuticals Inc
45.2M
-1.0x
---
United StatesACHL
Achilles Therapeutics PLC
43.6M
-0.6x
---
United StatesCALC
CalciMedica Inc
46.5M
-2.2x
---
As of 2024-11-23

Company Information

OKYO Pharma Limited is a United Kingdom-based clinical stage biopharmaceutical company developing therapies for the treatment of dry eye disease (DED) and neuropathic corneal pain (NCP). The Company is focused on the discovery and development of novel molecules to treat inflammatory DED and ocular pain. Its research program is focused on a novel G Protein-Coupled Receptor (GPCR). The Company is developing OK-101, its lead preclinical product candidate, for the treatment of DED. OK-101 is focused on keratoconjunctivitis sicca, commonly referred to as DED, which is a multifactorial disease caused by an underlying inflammation resulting in the lack of lubrication and moisture in the surface of the eye. The Company also plans to evaluate its potential in benefiting patients with ocular neuropathic pain, uveitis and allergic conjunctivitis. It is also evaluating OK-201, a bovine adrenal medulla (BAM), lipidated-peptide preclinical analogue candidate that is in the developmental stage.

Contact Information

Headquarters
Floor 4, 14/15 Conduit StLONDON, United Kingdom W1S 2XJ
Phone
207-495-2379
Fax
---

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$35.5M
Revenue (TTM)
$0.00
Shares Outstanding
33.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.69
Book Value
$-0.08
P/E Ratio
-1.5x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.